Cutaneous pigmentation irregularities: origins and contemporary removal techniques

Melanocytic nevi develop from the benign focal proliferation of melanocytes—specialized dendrite-bearing cells producing melanin within the basal epidermal layer. They may be congenital or acquired following exposure to ultraviolet radiation (UVA and UVB), which accelerates melanogenesis and DNA damage. Conversely, epidermal hyperpigmentation such as melasma and solar lentigines frequently stems from hormonal fluctuations (pregnancy, oral contraceptives), post-inflammatory hyperpigmentation (PIH), and chronic actinic elastosis.

Every pigmented lesion mandates systematic monitoring adhering to the international clinical ABCDE algorithm: A (Asymmetry), B (Border irregularity), C (Color variegation—patches of black, red, or blue), D (Diameter exceeding 5–6 mm), and E (Evolution—rapid morphologic change, pruritus, or bleeding). Any lesion meeting these criteria demands urgent dermatological evaluation via polarized dermatoscopy or digital videodermatoscopy, enabling early detection of cutaneous melanoma at a curable stage.

Suspicious melanocytic nevi must only be managed via surgical excision with histological safety margins, followed by mandatory histopathological verification; ablative lasers and cryotherapy are strictly contraindicated on unbiopsied nevi. For benign photo-induced hyperpigmentations and melasma, evidence-based dermatological modalities include chemical peels (azelaic, kojic, glycolic acids), picosecond pigment lasers, and topical tyrosinase inhibitors (vitamin C, alpha-arbutin, niacinamide), anchored by daily broad-spectrum SPF 50+ photoprotection.